Product Name
TPM2, Polyclonal Antibody
Popular Item
Full Product Name
TPM2 Antibody
Product Synonym Names
tropomyosin 2 (beta), DA1, DA2B, NEM4, TMSB, AMCD1
Product Gene Name
anti-TPM2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Specificity
The antibody detects endogenous level of total TPM2 protein.
Form/Format
Supplied at 1.5mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.3, 0.05% sodium azide and 50% glycerol.
Preparation and Storage
Store at -20°C/1 year
Other Notes
Small volumes of anti-TPM2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-TPM2 antibody
Background: This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. TPM2 has been shown to interact with RRAD, PDLIM7 and TPM1.
Product Categories/Family for anti-TPM2 antibody
Total protein Ab
Applications Tested/Suitable for anti-TPM2 antibody
ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC)
Application Notes for anti-TPM2 antibody
ELISA: 1:1000-1:5000
Western blotting: 1:2000-1:5000
Immunohistochemistry: 1:50-1:200
Testing Data of anti-TPM2 antibody
Gel: 10%SDS-PAGE
Lysate: 40 ug Human cervical cancer tissue lysate
Primary antibody: 1/750 dilution
Secondary antibody: Goat anti Rabbit IgG - H&L (HRP)
at 1/10000 dilution
Exposure time: 2 minutes

Immunohistochemistry (IHC) of anti-TPM2 antibody
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using MBS9406393 (TPM2 Antibody) at dilution 1/35, on the right is treated with the synthetic peptide.

NCBI/Uniprot data below describe general gene information for TPM2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_998839
[Other Products]
NCBI GenBank Nucleotide #
NM_213674.1
[Other Products]
UniProt Secondary Accession #
P06468; Q13894; Q53FM4; Q5TCU4; Q5TCU7; Q9UH67; A6NM85[Other Products]
UniProt Related Accession #
P07951[Other Products]
NCBI Official Full Name
tropomyosin beta chain isoform Tpm2.1sm/cy
NCBI Official Synonym Full Names
tropomyosin 2 (beta)
NCBI Official Symbol
TPM2 [Similar Products]
NCBI Official Synonym Symbols
DA1; DA2B; NEM4; TMSB; AMCD1; HEL-S-273
[Similar Products]
NCBI Protein Information
tropomyosin beta chain
UniProt Protein Name
Tropomyosin beta chain
UniProt Synonym Protein Names
Beta-tropomyosin; Tropomyosin-2
Protein Family
Tropomyosin
UniProt Gene Name
TPM2 [Similar Products]
UniProt Synonym Gene Names
TMSB [Similar Products]
UniProt Entry Name
TPM2_HUMAN
NCBI Summary for TPM2
This gene encodes beta-tropomyosin, a member of the actin filament binding protein family, and mainly expressed in slow, type 1 muscle fibers. Mutations in this gene can alter the expression of other sarcomeric tropomyosin proteins, and cause cap disease, nemaline myopathy and distal arthrogryposis syndromes. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
UniProt Comments for TPM2
TPM2: Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments. The non-muscle isoform may have a role in agonist-mediated receptor internalization. Defects in TPM2 are the cause of nemaline myopathy type 4 (NEM4). A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-or rod-like structures in muscle fibers on histologic examination. Nemaline myopathy type 4 presents from infancy to childhood with hypotonia and moderate-to-severe proximal weakness with minimal or no progression. Major motor milestones are delayed but independent ambulation is usually achieved, although a wheelchair may be needed in later life. Defects in TPM2 are the cause of distal arthrogryposis type 1A (DA1A). A form of distal arthrogryposis, a disease characterized by congenital joint flexures or contractures that mainly involve the distal parts of the limbs, and affect two or more different body areas in the absence of a primary neurological or muscle disease. Distal arthrogryposis type 1 is characterized largely by camptodactyly and clubfoot. Hypoplasia and/or absence of some interphalangeal creases is common. The shoulders and hips are less frequently affected. Belongs to the tropomyosin family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Motility/polarity/chemotaxis; Motor
Chromosomal Location of Human Ortholog: 9p13
Cellular Component: cytosol; muscle thin filament tropomyosin
Molecular Function: structural constituent of muscle; actin binding
Biological Process: regulation of ATPase activity; muscle contraction; muscle filament sliding
Disease: Nemaline Myopathy 4; Arthrogryposis, Distal, Type 1a; Myopathy, Congenital, With Fiber-type Disproportion; Arthrogryposis, Distal, Type 2b
Research Articles on TPM2
1. Changes for CRMP2, TCP1epsilon, TPM2 and 14-3-3gamma were confirmed in experimental tumors and in a series of 28 human SI-NETs.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.